The authors reply

New England Journal of Medicine

Volumn 370, Issue 19, 2014, Pages 1863-

  Wunderink, Richard G ^a   Waterer, Grant W ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; MACROLIDE; ANTIINFECTIVE AGENT;

COMBINATION CHEMOTHERAPY; COMMUNITY ACQUIRED PNEUMONIA; DRUG CHOICE; DRUG RESPONSE; DRUG USE; HUMAN; LETTER; MONOTHERAPY; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME; FEMALE; NOTE; PNEUMONIA;

ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; PNEUMONIA;

EID: 84899874093     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1402692     Document Type: Letter

References (5)

1. Brown RB, Iannini P, Gross P, Kunkel M. Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database. Chest 2003;123:1503-11. (Pubitemid 36549769)
2. Metersky ML, Ma A, Houck PM, Bratzler DW. Antibiotics for bacteremic pneumonia: improved outcomes with macrolides but not fluoroquinolones. Chest 2007;131:466-73. (Pubitemid 46280407)
3. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-86. (Pubitemid 30419053)
4. Ioannidis JP, Cappelleri JC, Lau J. Issues in comparisons between meta-analyses and large trials. JAMA 1998;279:1089-93. (Pubitemid 28177817)
5. Mitchell SL, Teno JM, Kiely DK, et al. The clinical course of advanced dementia. N Engl J Med 2009;361:1529-38.